Nathan Berman - Jun 30, 2021 Form 4 Insider Report for Exactus, Inc. (PLSH)

Signature
/s/ Nathan Berman
Stock symbol
PLSH
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/6/2021, 05:28 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSH Common Stock Award +497K 497K Jun 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSH Stock Options (Right to Buy) Award $0 +497K $0.00 497K Jun 30, 2021 Common Stock 497K $0.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock of the Issuer were acquired in exchange for shares of common stock of Panacea Life Sciences, Inc. ("Panacea"), in connection with the Securities Exchange Agreement dated June 30, 2021 by and among the Issuer, Panacea and the shareholders of Panacea.
F2 One-half of the stock options vest upon the effective date of a 1:28 reverse stock split of the Issuer's common stock, and the remainder vest on June 30, 2022, subject to continued employment with the Issuer.